RxDoctor Payments Data

Lisa Arkin, MD

Dermatology · Madison, WINPI 1639309941

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,895 of the $27,347 with a category attached, or 76.4%. Eli Lilly accounts for 68.7% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $19,054, 5.0 times the $3,795 reported in 2020. Among dermatology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,347in general payments, 2019–2025

Across 21 payments — averaging $1302.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$19K
  • Sanofi$4K
  • Regeneron$3K
  • AbbVie$675
  • Nobelpharma America, LLC$400
  • Chiesi USA, Inc.$162
  • plus $163 from 4 others
$1,352,256in research payments, 2019–2025

Across 60 payments — averaging $22,538 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$1.2M
  • Eli Lilly$101K
  • Bristol Myers Squibb$12K
  • EMD Serono, Inc.$2K
  • Incyte Corporation$45

What the payments were for

  • Consulting fees$20,89576%
  • Speaking & faculty fees$5,64621%
  • Travel & lodging$3181%
  • Food & beverage$4882%

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,347 in reported general payments places this provider in the 95th percentile of 260 dermatology providers in Wisconsin.

See all dermatology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$32,423
Medicare patients
169
Services billed
476

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab15$32,967
Clobetasol Propionate21$801
Ketoconazole20$489
Triamcinolone Acetonide23$324
Minoxidil16$224

Paid to pharmacies, not to this prescriber.

Other dermatology in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →